Luteolin antagonizes angiotensin II-dependent proliferation and collagen synthesis of cultured rat cardiac fibroblasts.
OBJECTIVE
The purpose of this study was to observe if luteolin could affect the behavior of cardiac fibroblasts (CFs) on myocardial fibrosis stimulated by angiotensin II (Ang II) and investigate the mechanism involved.


METHODS
MTT was used to observe the CFs viability and proliferation which was also detected by an EdU staining kit. Cell migration was determined by the transwell chamber. Western blotting was used to examine the protein expression levels of a smooth muscle actin (α-SMA), collagen I and collagen III. The activity of nitric oxide (NO), synthase (NOS), nitrite and cyclic GMP (cGMP) content were measured according to the kits and an enzyme linked immunosorbent assay (ELISA) respectively.


RESULTS
The proliferation, migration and expression of α-SMA, collagen I and collagen III in CFs stimulated by Ang II were inhibited by luteolin treatment, and these effects were partly blocked by a combination of treatment with Ang II and NG-nitro-Larginine methyl ester (L-NAME), a non-selective NOS inhibitor, also with 1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one (ODQ), a specific inhibitor of guanylyl cyclase. These effects did not include CFs migration, which showed no apparent difference between Ang II single and together with inhibitors. Luteolin increased the synthesis of total NOS and the content of nitrite and cGMP.


CONCLUSIONS
These results demonstrate that luteolin is capable of inhibiting the behavior of CFs stimulated by Ang II via up-regulation of NO-cGMP signal pathway.
Tingting
T
Wang
Defeng
D
Pan
Yingying
Y
Zhang
Dongye
D
Li
Yanbin
Y
Zhang
Tongda
T
Xu
Yuanyuan
Y
Luo
Institute of Cardiovascular Research and Department of Cardiology, Affiliated Hospital of Xuzhou Medical College, Xuzhou 221002, China. dongyeli@medmail.com.cn.
Yanfeng
Y
Ma
D000199:Actins / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D003094:Collagen / Q000378:metabolism*; D024042:Collagen Type I / Q000378:metabolism; D024061:Collagen Type III / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism; D005347:Fibroblasts / Q000187:drug effects* / Q000378:metabolism; D047311:Luteolin / Q000494:pharmacology*; D009206:Myocardium / Q000166:cytology; D009569:Nitric Oxide / Q000378:metabolism; D017207:Rats, Sprague-Dawley
D000199:Actins; D000804:Angiotensin II; D003094:Collagen; D024042:Collagen Type I; D024061:Collagen Type III; D006152:Cyclic GMP; D047311:Luteolin; D009569:Nitric Oxide; C498862:Acta2 protein, rat